Science Explorer Back to mapMap
Discussion
Company · Wurzburg · Germany

Patrys (Germany)

Research works
4
fractional, all time
Citations
203
57.5 per fractional work
Top-10% rate
33.7%
all institutions 10.0%
Open access
82%
world 40%
International
72%
world 18%

Not ranked overall: Patrys (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Patrys (Germany) work in?

In all years, 54% of research at Patrys (Germany) is in Life Sciences, 41% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (43%), Medicine (41%), Immunology and Microbiology (11%). It does 1.4× the world's share of Life Sciences.

Life Sciences54%Physical Sciences5%Health Sciences41%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology243.2%
    2. Immunology and Microbiology010.8%
    1. Medicine240.5%
    1. Materials Science05.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Patrys (Germany)?

The most cited paper from Patrys (Germany) is "A new tumor-specific variant of GRP78 as target for antibody-based therapy" (Nicole Rauschert, Stephanie Brändlein, Elisabeth Holzinger et al., 2008), with 130 citations. Next come "GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6" (101) and "Expression and glycoengineering of functionally active heteromultimeric IgM in plants" (85).

Most cited papers
#PaperReleasedCitations
1 A new tumor-specific variant of GRP78 as target for antibody-based therapy Nicole Rauschert, Stephanie Brändlein, Elisabeth Holzinger et al. · Laboratory Investigation Open access 11 Feb 2008 130
2 GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 Leo Rasche, Johannes Duell, Inês C. Castro et al. · Haematologica Open access 30 Jan 2015 101
3 Expression and glycoengineering of functionally active heteromultimeric IgM in plants Andreas Loos, Clemens Grünwald‐Gruber, Friedrich Altmann et al. · Proceedings of the National Academy of Sciences Open access 31 Mar 2014 85
4 The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78 Leo Rasche, Johannes Duell, Charlotte Morgner et al. · PLoS ONE Open access 7 May 2013 68
5 High level expression of functional human IgMs in human PER.C6® cells Anna Tchoudakova, Frank Hensel, Alec Murillo et al. · mAbs Open access Mar 2009 63
All 10 most cited papers, with filters and sorting

Which research topics does Patrys (Germany) publish most on?

By volume: Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Endoplasmic Reticulum Stress and Disease and Multiple Myeloma Research and Treatments.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  3. 3 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
  4. 4 Multiple Myeloma Research and Treatments Hematology 0 works
  5. 5 Transgenic Plants and Applications Biotechnology 0 works
  6. 6 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  7. 7 Protein purification and stability Molecular Biology 0 works
  8. 8 Galectins and Cancer Biology Immunology 0 works
  9. 9 Microbial Inactivation Methods Biotechnology 0 works
  10. 10 PARP inhibition in cancer therapy Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.6%not open18.4%

World: 40% of research is openly available.

with international co-authors72.4%domestic only27.6%

World: 18% is written across borders.

How has Patrys (Germany)'s research output changed?

20102015
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Wurzburg

All research institutions in Wurzburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Patrys (Germany). Posts are plain text and can be reported.